Want to join the conversation?
$HALO's cost of product sales were $6.2MM in 3Q15 compared to $5.1MM in 3Q14. The increase of $1.1MM was due to a $1.2MM increase in bulk rHuPH20 sales to collaboration partners offset by a $0.2MM decrease in Hylenex recombinant cost of product sales. The company's interest expense remained constant at $1.3MM in 3Q15 versus $1.4MM in 3Q14.
$AAL is getting stronger into Dec. after a strong Nov..!! I’m feeling confident about their 4Q revenue forecast for a margin rise.
$KO’s CEO Muhtar Kent to step down next year. COO James Quincey will take the helm in what is already a smooth sailing scenario. And as always, shares reflect by growing 2% after the market opened.